Summary
347.18 -3.93(-1.12%)05/13/2024
Waters Corp. (WAT)
Waters Corp. (WAT)
Key Facts
1 Day | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 5 Years | All Time |
2.06 | 5.63 | -3.71 | 0.97 | 25.23 | 10.10 | 53.11 | 8,582.97 |
Last 730 data points are shown. To view all data, Upgrade to PRO plan with only $1
Trading Data | ||
Close | 326.45 | |
Open | 326.68 | |
High | 331.47 | |
Low | 313.99 | |
Volume | 875,828 | |
Change | 6.59 | |
Change % | 2.06 | |
Avg Volume (20 Days) | 486,564 | |
Volume/Avg Volume (20 Days) Ratio | 1.80 | |
52 Week Range | 231.90 - 363.79 | |
Price vs 52 Week High | -10.27% | |
Price vs 52 Week Low | 40.77% | |
Range | -0.07 | |
Gap Up/Down | 1.52 |
Fundamentals | ||
Market Capitalization (Mln) | 20,828 | |
EBIDTA | 962,024,000 | |
PE Ratio | 38.9867 | |
PEG Ratio | 2.3698 | |
WallStreet Target Price | 360.08 | |
Book Value | 4.8260 | |
Earnings Per Share | 11.1515 | |
EPS Estimate Current Quarter | 2.3500 | |
EPS Estimate Next Quarter | 3.4300 | |
EPS Estimate Current Year | 11.0200 | |
EPS Estimate Next Year | 11.7900 | |
Diluted EPS (TTM) | 11.1600 | |
Revenues | ||
Profit Marging | 0.2540 | |
Operating Marging (TTM) | 0.3033 | |
Return on asset (TTM) | 0.1790 | |
Return on equity (TTM) | 547.9517 | |
Revenue TTM | 2,736,082,944 | |
Revenue per share TTM | 44.2160 | |
Quarterly Revenue Growth (YOY) | 0.1100 | |
Quarterly Earnings Growth (YOY) | 0.2810 | |
Gross Profit (TTM) | 1,358,676,000 |
Dividends | ||
Dividend Share | 0.0000 | |
Dividend Yield | ||
Valuations | ||
Trailing PE | 30.6487 | |
Forward PE | 28.5714 | |
Price Sales (TTM) | 0.0000 | |
Price Book (MRQ) | 70.4925 | |
Revenue Enterprise Value | 7.9875 | |
EBITDA Enterprise Value | 22.1103 | |
Shares | ||
Shares Outstanding | 61,036,300 | |
Shares Float | 60,677,376 | |
Shares Short | 0 | |
Shares Short (Prior Month) | 0 | |
Shares Ratio | 0.00 | |
Short Outstanding (%) | 0.00 | |
Short Float (%) | 0.00 | |
Insider (%) | 0.62 | |
Institutions (%) | 91.46 |
05/13 14:00 EST - PRNewsWire
Waters Corporation to Present at the Jefferies 2024 Healthcare Conference
MILFORD, Mass. , May 13, 2024 /PRNewswire/ -- Waters Corporation (NYSE:WAT) announced that Udit Batra Ph.D.
Waters Corporation to Present at the Jefferies 2024 Healthcare Conference
MILFORD, Mass. , May 13, 2024 /PRNewswire/ -- Waters Corporation (NYSE:WAT) announced that Udit Batra Ph.D.
05/13 12:36 EST - Zacks Investment Research
Waters (WAT) International Revenue in Focus: Trends and Expectations
Examine Waters' (WAT) international revenue patterns and their implications on Wall Street's forecasts and the prospective trajectory of the stock.
Waters (WAT) International Revenue in Focus: Trends and Expectations
Examine Waters' (WAT) international revenue patterns and their implications on Wall Street's forecasts and the prospective trajectory of the stock.
05/07 13:51 EST - Zacks Investment Research
Waters (WAT) Q1 Earnings & Sales Beat Estimates, Fall Y/Y
Waters' (WAT) first-quarter results are hurt by weak end-market momentum and softness in Asia.
Waters (WAT) Q1 Earnings & Sales Beat Estimates, Fall Y/Y
Waters' (WAT) first-quarter results are hurt by weak end-market momentum and softness in Asia.
05/07 10:36 EST - Zacks Investment Research
Compared to Estimates, Waters (WAT) Q1 Earnings: A Look at Key Metrics
The headline numbers for Waters (WAT) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Compared to Estimates, Waters (WAT) Q1 Earnings: A Look at Key Metrics
The headline numbers for Waters (WAT) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
05/06 12:16 EST - Zacks Investment Research
Waters (WAT) to Report Q1 Earnings: What's in the Offing?
Waters' (WAT) first-quarter 2024 results are likely to reflect strength in the large molecule and PFAS testing markets amid weakening demand in China.
Waters (WAT) to Report Q1 Earnings: What's in the Offing?
Waters' (WAT) first-quarter 2024 results are likely to reflect strength in the large molecule and PFAS testing markets amid weakening demand in China.
05/02 10:21 EST - Zacks Investment Research
Unlocking Q1 Potential of Waters (WAT): Exploring Wall Street Estimates for Key Metrics
Beyond analysts' top -and-bottom-line estimates for Waters (WAT), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended March 2024.
Unlocking Q1 Potential of Waters (WAT): Exploring Wall Street Estimates for Key Metrics
Beyond analysts' top -and-bottom-line estimates for Waters (WAT), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended March 2024.
04/11 14:00 EST - PRNewsWire
Waters Corporation Schedules First Quarter 2024 Earnings Conference Call
MILFORD, Mass. , April 11, 2024 /PRNewswire/ -- Waters Corporation (NYSE:WAT) will hold its Q1 2024 financial results conference call live on Tuesday, May 7th, 2024 at 8:00 a.m.
Waters Corporation Schedules First Quarter 2024 Earnings Conference Call
MILFORD, Mass. , April 11, 2024 /PRNewswire/ -- Waters Corporation (NYSE:WAT) will hold its Q1 2024 financial results conference call live on Tuesday, May 7th, 2024 at 8:00 a.m.
04/11 10:16 EST - Zacks Investment Research
Waters (WAT) Boosts Waters Operating Segment With HPLC System
Waters (WAT) launches Alliance iS Bio HPLC system to improve efficiency across biopharma QC laboratories, boosting its Waters Operating segment.
Waters (WAT) Boosts Waters Operating Segment With HPLC System
Waters (WAT) launches Alliance iS Bio HPLC system to improve efficiency across biopharma QC laboratories, boosting its Waters Operating segment.
03/18 12:20 EST - Zacks Investment Research
Waters (WAT) Boosts PFAS Testing Solutions With New Cartridges
Waters (WAT) launches Oasis WAX/GCB and GCB/WAX Cartridges for PFAS testing, thus boosting the Waters Operating segment.
Waters (WAT) Boosts PFAS Testing Solutions With New Cartridges
Waters (WAT) launches Oasis WAX/GCB and GCB/WAX Cartridges for PFAS testing, thus boosting the Waters Operating segment.
03/15 11:06 EST - Zacks Investment Research
Waters (WAT) Boosts Portfolio Strength With Rheo-IS Accessory
Waters (WAT) unveils Rheo-IS accessory for its TA Instruments Discovery Hybrid Rheometers, bolstering its overall portfolio.
Waters (WAT) Boosts Portfolio Strength With Rheo-IS Accessory
Waters (WAT) unveils Rheo-IS accessory for its TA Instruments Discovery Hybrid Rheometers, bolstering its overall portfolio.
03/07 12:36 EST - Zacks Investment Research
Why Is Waters (WAT) Up 7.9% Since Last Earnings Report?
Waters (WAT) reported earnings 30 days ago. What's next for the stock?
Why Is Waters (WAT) Up 7.9% Since Last Earnings Report?
Waters (WAT) reported earnings 30 days ago. What's next for the stock?
02/29 11:16 EST - Zacks Investment Research
Waters (WAT) Boosts LC Solutions Portfolio With New Software
Waters (WAT) unveils HPLC CONNECT software, bolstering its liquid chromatography solutions portfolio.
Waters (WAT) Boosts LC Solutions Portfolio With New Software
Waters (WAT) unveils HPLC CONNECT software, bolstering its liquid chromatography solutions portfolio.
02/22 14:00 EST - PRNewsWire
Waters Corporation to Present at the TD Cowen 44th Annual Health Care Conference
MILFORD, Mass. , Feb. 22, 2024 /PRNewswire/ -- Waters Corporation (NYSE:WAT) announced that Udit Batra Ph.D.
Waters Corporation to Present at the TD Cowen 44th Annual Health Care Conference
MILFORD, Mass. , Feb. 22, 2024 /PRNewswire/ -- Waters Corporation (NYSE:WAT) announced that Udit Batra Ph.D.
02/15 06:11 EST - InvestorPlace
Buy the Dip: 3 Oversold Stocks Poised for Big Gains
Traders can benefit from applying Relative Strength Index (RSI) signals in prevailing market conditions. One approach to consider which oversold stocks to buy is to wait for the RSI to cross back above 30% before considering an entry.
Buy the Dip: 3 Oversold Stocks Poised for Big Gains
Traders can benefit from applying Relative Strength Index (RSI) signals in prevailing market conditions. One approach to consider which oversold stocks to buy is to wait for the RSI to cross back above 30% before considering an entry.
02/06 14:36 EST - Zacks Investment Research
Waters (WAT) Q4 Earnings & Sales Beat Estimates, Fall Y/Y
Waters' (WAT) fourth-quarter results reflect weak end-market momentum. Also, softness in Asia is concerning.
Waters (WAT) Q4 Earnings & Sales Beat Estimates, Fall Y/Y
Waters' (WAT) fourth-quarter results reflect weak end-market momentum. Also, softness in Asia is concerning.
02/06 12:50 EST - Seeking Alpha
Waters Corporation (WAT) Q4 2023 Earnings Call Transcript
Waters Corporation (WAT) Q4 2023 Earnings Call Transcript
Waters Corporation (WAT) Q4 2023 Earnings Call Transcript
Waters Corporation (WAT) Q4 2023 Earnings Call Transcript
02/06 10:46 EST - Zacks Investment Research
Waters (WAT) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
The headline numbers for Waters (WAT) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Waters (WAT) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
The headline numbers for Waters (WAT) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
02/06 09:05 EST - Zacks Investment Research
Waters (WAT) Beats Q4 Earnings and Revenue Estimates
Waters (WAT) came out with quarterly earnings of $3.62 per share, beating the Zacks Consensus Estimate of $3.56 per share. This compares to earnings of $3.84 per share a year ago.
Waters (WAT) Beats Q4 Earnings and Revenue Estimates
Waters (WAT) came out with quarterly earnings of $3.62 per share, beating the Zacks Consensus Estimate of $3.56 per share. This compares to earnings of $3.84 per share a year ago.
02/02 11:06 EST - Zacks Investment Research
Waters (WAT) to Report Q4 Earnings: What's in the Offing?
Waters' (WAT) fourth-quarter 2023 results are likely to reflect strength in the large molecule market and Waters services business amid weakening demand in China.
Waters (WAT) to Report Q4 Earnings: What's in the Offing?
Waters' (WAT) fourth-quarter 2023 results are likely to reflect strength in the large molecule market and Waters services business amid weakening demand in China.
02/01 10:21 EST - Zacks Investment Research
What Analyst Projections for Key Metrics Reveal About Waters (WAT) Q4 Earnings
Get a deeper insight into the potential performance of Waters (WAT) for the quarter ended December 2023 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
What Analyst Projections for Key Metrics Reveal About Waters (WAT) Q4 Earnings
Get a deeper insight into the potential performance of Waters (WAT) for the quarter ended December 2023 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.